Glenview Capital Management fully unloaded one of its largest and oldest positions in the second quarter.
According to its second-quarter 13F filing, made public late Thursday, the healthcare-heavy hedge fund firm headed by Larry Robbins liquidated its stake in drug giant Bausch Health Companies.
Glenview
